Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Melder

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|March 20, 1991
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculationA Sasaki, R J Melder, T L Whiteside, et al.
Journal of Immunological Methods|September 30, 1994
A method for labeling cells for positron emission tomography (PET) studiesR J Melder, D Elmaleh, A L Brownell, et al.
Nature Biotechnology|August 1, 1997
Solid stress inhibits the growth of multicellular tumor spheroidsG Helmlinger, P A Netti, H C Lichtenbeld, et al.
Cancer Research|December 15, 1993
Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumorsR J Melder, A L Brownell, T M Shoup, et al.
Cancer Research|June 15, 1988
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cellsR J Melder, T L Whiteside, N L Vujanovic, et al.
Cancer Metastasis Reviews|June 1, 1996
Leukocyte-endothelial adhesion and angiogenesis in tumorsR K Jain, G C Koenig, M Dellian, et al.
Cancer Research|November 1, 1995
Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strainD Fukumura, H A Salehi, B Witwer, et al.
AIDS Research and Human Retroviruses|August 1, 1990
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cellsR J Melder, R Balachandran, C R Rinaldo, et al.
Nature Medicine|September 1, 1996
During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endotheliumR J Melder, G C Koenig, B P Witwer, et al.
British Journal of Cancer|November 11, 1999
Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicityM A Swartz, C A Kristensen, R J Melder, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|March 20, 1991
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculationA Sasaki, R J Melder, T L Whiteside, et al.
Journal of Immunological Methods|September 30, 1994
A method for labeling cells for positron emission tomography (PET) studiesR J Melder, D Elmaleh, A L Brownell, et al.
Nature Biotechnology|August 1, 1997
Solid stress inhibits the growth of multicellular tumor spheroidsG Helmlinger, P A Netti, H C Lichtenbeld, et al.
Cancer Research|December 15, 1993
Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumorsR J Melder, A L Brownell, T M Shoup, et al.
Cancer Research|June 15, 1988
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cellsR J Melder, T L Whiteside, N L Vujanovic, et al.
Cancer Metastasis Reviews|June 1, 1996
Leukocyte-endothelial adhesion and angiogenesis in tumorsR K Jain, G C Koenig, M Dellian, et al.
Cancer Research|November 1, 1995
Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strainD Fukumura, H A Salehi, B Witwer, et al.
AIDS Research and Human Retroviruses|August 1, 1990
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cellsR J Melder, R Balachandran, C R Rinaldo, et al.
Nature Medicine|September 1, 1996
During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endotheliumR J Melder, G C Koenig, B P Witwer, et al.
British Journal of Cancer|November 11, 1999
Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicityM A Swartz, C A Kristensen, R J Melder, et al.
Pageof 4